Phathom Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
80.1M
on 2026-06-30, from 58.5M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
No limit
S-3ASR of 2026-01-07. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-07-30 is not read yet.
Cash
19.9 quarters
$182.5M on 2026-06-30 ÷ $9.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-01-07 | Public offering incl. 1.25M pre-funded | 8,125,078 | $16.00 | $130.0M | 424B5 ↗ |